InsidersTradesSigma
Discover the full record of transactions filed by SCANGOS GEORGE A, Chief Executive Officer. Officer active across 2 companies, notably Vir Biotechnology, Inc.. In total, 3 filings have been recorded. Total volume traded: €281k. The latest transaction was filed on 10 March 2022 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
3 of 3 declarations
George A. Scangos is the President and CEO of Vir Biotechnology, Inc. and Agilent Technologies, Inc. He leads corporate strategies and growth initiatives, focusing on innovation in the biotechnology sector. His experience is a significant asset to both companies.